Dr. Homa began with Nuventra in 2017 after receiving his Ph.D. from the Department of Molecular Genetics & Microbiology at Duke University, where his work focused on cancer biology, primarily in hematologic malignancies, as well as infectious disease and virology. He is specifically interested in oncology and cancer biology, as well as rare diseases.
Education